A Phase 1 Research Study to Evaluate Safety, Tolerability, and Pharmacokinetics of WVE-006 in Healthy Participants With Wild-type AAT Expression (RestorAATion-1)
Clinical trial NCT06186492 · COMPLETED
Trial details
- NCT number
- NCT06186492
- Sponsor
- Wave Life Sciences USA, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-14
- Primary completion
- 2025-02-13
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.